Search By:
Products
Injury
Topic
Company
Industry
Avandia may increase risk of heart problems and bone fracture.
Investigation Source
- Nationwide
Investigation Scope
Category Information
Investigation Topic
- Increased Risk of Bodily Injury
Product or Service
- Avandia
Injury Types
- Heart Attack
- Primary Pulmonary Hypertension
- Bone Fracture
Investigation Details
On going investigation against GlaxoSmithKline in connection with its drug, Avandia. Avandia was designed to treat type II diabetes. Avandia, the drug developed, marketed and distributed to treat Type II diabetes mellitus, caused serious side effects, notably cardiovascular problems, including heart attack, heart failure, and primary pulmonary hypertension ("HPP"). Moreover, women taking Avandia may be exposed to a higher risk of bone fracture. On June 14, 2007, the New England Journal of Medicine released a study which found that there was an increased risk of heart attacks by 43%. On November 14, 2007, the Food & Drug Administration required GlaxoSmithKline add a "black box" to the label warning consumers of s cardiovascular risk.
Do not change medications without first consulting your doctor.
Do not change medications without first consulting your doctor.
Defendant Details
| Name (Stock Symbol) | Brief Description |
|---|---|
| GlaxoSmithKline PLC (GSK) | GlaxoSmithKline plc, is a pharmaceutical company. |